Clinical Trials and Current Research
| Dates: |
Thursday, March 28 |
| Time: |
12:00pm - 1:00pm PT |
| Fee: |
Free |
Dive into the latest advancements in Parkinson's disease research with Dr. Matthew Deen! Join us for an engaging webinar where Dr. Deen will unravel the fundamentals of clinical trials and their role in evaluating new therapies. Get insights into cutting-edge treatments like alpha-synuclein and GBA/LRRK2, along with a glimpse into the methods used to measure their effectiveness. Don't miss this opportunity to stay informed and empowered!
Dr. Matthew Deen, a chemical biologist, is currently engaged in post-doctoral research under Prof. Wennemers at ETH Zurich. Previously, during his doctoral studies under Prof. David Vocadlo at Simon Fraser University, he specialized in developing innovative methods for studying Parkinson's disease (PD) biology. As a key member of Prof. Vocadlo's lab, he applied these methods to identify novel therapies for PD and played a crucial role in developing a groundbreaking clinical diagnostic tool. Dr. Deen's groundbreaking work has garnered support from the Michael J. Fox Foundation and Parkinson Society British Columbia.
 |
Parkinson Society BC appreciates all gifts, as they allow us to continue to offer programs people with Parkinson's disease and their carepartners rely on. If you wish, you can make a donation by entering an amount in the Additional Donation field. |
IMPORTANT: After registering through this form, please make sure to click the Zoom link that appears on the confirmation screen and input your name and email address. This will ensure you are fully registered for the event and get the access link.
Please note: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. Please note that any Q&A sessions that take place will not be recorded.